This inventor holds 1 USPTO granted patent. Top assignee: Precigen, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Cerrone - Innovator in Electroporation Technology
Introduction
David Cerrone is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly through his innovative work on electroporation technology. His expertise and inventions have the potential to advance medical and scientific applications.
Latest Patents
David Cerrone holds a patent for an "Electroporation apparatus and method." This technology involves applying an electrical field to cells to enhance the permeability of their membranes. This process allows for the introduction of various substances, including chemicals, drugs, proteins, and nucleic acids, into the cells. The electroporation apparatus consists of multiple chambers designed to store cells during the electroporation process, electrodes to generate electric fields, a flow channel for cell transport, and valves connecting the chambers to the flow channel. He has 1 patent to his name.
Career Highlights
Cerrone's career is marked by his role at Precigen, Inc., where he has been instrumental in developing cutting-edge technologies. His work focuses on enhancing the efficiency and effectiveness of electroporation techniques, which are crucial for various applications in biotechnology and medicine.
Collaborations
Throughout his career, David has collaborated with talented individuals such as Bryan Butman and Jonathan Carson. These partnerships have fostered innovation and contributed to the advancement of electroporation technology.
Conclusion
David Cerrone's contributions to electroporation technology exemplify the impact of innovative thinking in biotechnology. His work continues to pave the way for new possibilities in the introduction of therapeutic agents into cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
